| Cardiomyopathy and Myosin Studies | Lifetime | 49 | US 34 | 99.54 |
| Cardiac Structural Anomalies and Repair | Lifetime | 87 | US 59 | 99.65 |
| Cardiovascular Function and Risk Factors | Lifetime | 155 | US 99 | 99.69 |
| Cardiac Valve Diseases and Treatments | Lifetime | 145 | US 89 | 99.66 |
| Cardiac Imaging and Diagnostics | Lifetime | 229 | US 122 | 99.60 |
| Cardiovascular Effects of Exercise | Lifetime | 107 | US 53 | 99.18 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 206 | US 103 | 99.13 |
| Aortic Disease and Treatment Approaches | Lifetime | 220 | US 128 | 98.89 |
| Congenital Heart Disease Studies | Lifetime | 543 | US 305 | 98.00 |
| Cardiovascular Disease and Adiposity | Lifetime | 658 | US 322 | 96.84 |
| Viral Infections and Immunology Research | Lifetime | 730 | US 318 | 96.62 |
| Pericarditis and Cardiac Tamponade | Lifetime | 335 | US 155 | 92.57 |
| Cardiac tumors and thrombi | Lifetime | 951 | US 444 | 92.84 |
| Aortic Thrombus and Embolism | Lifetime | 108 | US 54 | 91.23 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 550 | US 249 | 91.20 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 275 | US 93 | 89.49 |
| Williams Syndrome Research | Lifetime | 838 | US 331 | 50.96 |
| Cardiomyopathy and Myosin Studies | 2021-2025 | 4 | US 2 | 99.74 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 27 | US 12 | 99.48 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 45 | US 25 | 99.68 |
| Viral Infections and Immunology Research | 2021-2025 | 29 | US 9 | 97.79 |
| Cardiac Valve Diseases and Treatments | 2021-2025 | 100 | US 49 | 99.24 |
| Cardiovascular Effects of Exercise | 2021-2025 | 40 | US 11 | 98.42 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 257 | US 102 | 96.94 |
| Congenital Heart Disease Studies | 2021-2025 | 219 | US 114 | 95.73 |
| Infective Endocarditis Diagnosis and Management | 2021-2025 | 301 | US 121 | 96.17 |
| Aortic Disease and Treatment Approaches | 2021-2025 | 270 | US 118 | 95.07 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 329 | US 90 | 89.98 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 943 | US 257 | 94.34 |
| Trypanosoma species research and implications | 2021-2025 | 393 | US 57 | 86.40 |
| Williams Syndrome Research | 2021-2025 | 56 | US 18 | 61.92 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 738 | US 159 | 44.87 |
| Firm Innovation and Growth | 2021-2025 | 908 | US 166 | 43.51 |
| Innovation Policy and R&D | 2021-2025 | 905 | US 99 | 33.28 |
